These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 206840

  • 21. [Epstein-Barr virus (EBV) infection associated with nasopharyngeal carcinoma].
    Furukawa M.
    Gan To Kagaku Ryoho; 1990 Apr; 17(4 Pt 1):601-7. PubMed ID: 2157366
    [Abstract] [Full Text] [Related]

  • 22. Clinical values of multiple Epstein-Barr virus (EBV) serological biomarkers detected by xMAP technology.
    Gu AD, Lu LX, Xie YB, Chen LZ, Feng QS, Kang T, Jia WH, Zeng YX.
    J Transl Med; 2009 Aug 23; 7():73. PubMed ID: 19698162
    [Abstract] [Full Text] [Related]

  • 23. Studies on etiological factors of nasopharyngeal carcinoma.
    Zheng X, Christensson B, Drettner B.
    Acta Otolaryngol; 1993 May 23; 113(3):455-7. PubMed ID: 8390773
    [Abstract] [Full Text] [Related]

  • 24. The prevalence and prevention of nasopharyngeal carcinoma in China.
    Cao SM, Simons MJ, Qian CN.
    Chin J Cancer; 2011 Feb 23; 30(2):114-9. PubMed ID: 21272443
    [Abstract] [Full Text] [Related]

  • 25. Evaluation of plasma Epstein-Barr virus DNA load to distinguish nasopharyngeal carcinoma patients from healthy high-risk populations in Southern China.
    Ji MF, Huang QH, Yu X, Liu Z, Li X, Zhang LF, Wang P, Xie SH, Rao HL, Fang F, Guo X, Liu Q, Hong MH, Ye W, Zeng YX, Cao SM.
    Cancer; 2014 May 01; 120(9):1353-60. PubMed ID: 24477877
    [Abstract] [Full Text] [Related]

  • 26. Lack of association between cigarette smoking and Epstein Barr virus reactivation in the nasopharynx in people with elevated EBV IgA antibody titres.
    Chen Y, Xu Y, Zhao W, Xiao X, Zhou X, Lin L, Huang T, Liao J, Li Y, Zeng X, Huang G, Ye W, Zhang Z.
    BMC Cancer; 2018 Feb 14; 18(1):190. PubMed ID: 29444646
    [Abstract] [Full Text] [Related]

  • 27. Quantification of Epstein-Barr virus DNA load in nasopharyngeal brushing samples in the diagnosis of nasopharyngeal carcinoma in southern China.
    Zheng XH, Lu LX, Li XZ, Jia WH.
    Cancer Sci; 2015 Sep 14; 106(9):1196-201. PubMed ID: 26082292
    [Abstract] [Full Text] [Related]

  • 28. The Evolving Epidemiology of Nasopharyngeal Carcinoma.
    Chang ET, Ye W, Zeng YX, Adami HO.
    Cancer Epidemiol Biomarkers Prev; 2021 Jun 14; 30(6):1035-1047. PubMed ID: 33849968
    [Abstract] [Full Text] [Related]

  • 29. Evaluation of nonviral risk factors for nasopharyngeal carcinoma in a high-risk population of Southern China.
    Guo X, Johnson RC, Deng H, Liao J, Guan L, Nelson GW, Tang M, Zheng Y, de The G, O'Brien SJ, Winkler CA, Zeng Y.
    Int J Cancer; 2009 Jun 15; 124(12):2942-7. PubMed ID: 19296536
    [Abstract] [Full Text] [Related]

  • 30. [Epstein-Barr virus--a clinically relevant feature of nasopharyngeal carcinoma? (author's transl)].
    Wilmes E, Wolf H, Deinhardt F, Naumann HH.
    Laryngol Rhinol Otol (Stuttg); 1981 Jan 15; 60(1):4-6. PubMed ID: 6261051
    [Abstract] [Full Text] [Related]

  • 31. Human nasopharyngeal carcinomas positive for Epstein-Barr virus DNA in North America.
    Glaser R, Nonoyama M, Szymanowski RT, Graham W.
    J Natl Cancer Inst; 1980 Jun 15; 64(6):1317-9. PubMed ID: 6246300
    [Abstract] [Full Text] [Related]

  • 32. Evaluation of a semi-quantitative ELISA for IgA antibody against Epstein-Barr virus capsid antigen in the serological diagnosis of nasopharyngeal carcinoma.
    Chen H, Chi P, Wang W, Li L, Luo Y, Fu J, Zhang L, Liu W.
    Int J Infect Dis; 2014 Aug 15; 25():110-5. PubMed ID: 24878579
    [Abstract] [Full Text] [Related]

  • 33. Epidemiologic, etiologic and immunologic aspects of nasopharyngeal carcinoma [NPC].
    Gastpar H, Wilmes E, Wolf H.
    J Med; 1981 Aug 15; 12(4):257-84. PubMed ID: 6273487
    [No Abstract] [Full Text] [Related]

  • 34. Evaluation of antibodies to Epstein-Barr virus in Italian patients with nasopharyngeal carcinoma.
    Cevenini R, Donati M, Caliceti U, Moroni A, Tamba I, Rumpianesi F.
    J Infect; 1986 Mar 15; 12(2):127-31. PubMed ID: 3009628
    [Abstract] [Full Text] [Related]

  • 35. The Relationship Between Environmental Factors and the Profile of Epstein-Barr Virus Antibodies in the Lytic and Latent Infection Periods in Healthy Populations from Endemic and Non-Endemic Nasopharyngeal Carcinoma Areas in China.
    He YQ, Xue WQ, Xu FH, Xu YF, Zhang JB, Yu HL, Feng QS, Chen LZ, Cao SM, Liu Q, Mu J, Zeng YX, Jia WH.
    EBioMedicine; 2018 Apr 15; 30():184-191. PubMed ID: 29606628
    [Abstract] [Full Text] [Related]

  • 36. Interaction of factors associated with cancer of the nasopharynx.
    Lin TM, Yang CS, Tu SM, Chen CJ, Kuo KC, Hirayama T.
    Cancer; 1979 Oct 15; 44(4):1419-23. PubMed ID: 227565
    [Abstract] [Full Text] [Related]

  • 37. Multiple risk factors of nasopharyngeal carcinoma: Epstein-Barr virus, malarial infection, cigarette smoking and familial tendency.
    Chen CJ, Liang KY, Chang YS, Wang YF, Hsieh T, Hsu MM, Chen JY, Liu MY.
    Anticancer Res; 1990 Oct 15; 10(2B):547-53. PubMed ID: 2161639
    [Abstract] [Full Text] [Related]

  • 38. Molecular diversity of Epstein-Barr virus IgG and IgA antibody responses in nasopharyngeal carcinoma: a comparison of Indonesian, Chinese, and European subjects.
    Fachiroh J, Schouten T, Hariwiyanto B, Paramita DK, Harijadi A, Haryana SM, Ng MH, Middeldorp JM.
    J Infect Dis; 2004 Jul 01; 190(1):53-62. PubMed ID: 15195243
    [Abstract] [Full Text] [Related]

  • 39. [Rhinopharyngeal carcinoma and Epstein-Barr virus: study of a sample of Italian patients].
    Caliceti U, Cevenini R, Donati M.
    Acta Otorhinolaryngol Ital; 1985 Jul 01; 5(1):83-90. PubMed ID: 2994355
    [No Abstract] [Full Text] [Related]

  • 40. Epstein-Barr virus-specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma.
    Henle G, Henle W.
    Int J Cancer; 1976 Jan 15; 17(1):1-7. PubMed ID: 175020
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.